METABASIS THERAPEUTICS INC
METABASIS THERAPEUTICS INC (MBRX) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 137 transactions totaling $10.8M, demonstrating a bullish sentiment with $9.2M in net insider flow. The most recent transaction on Jul 2, 2024 involved a transaction of 982 shares valued at $0.
MBRX Insider Activity Summary
Who Is Buying MBRX Stock?
No significant insider buying has been recorded for MBRX in the recent period.
Who Is Selling MBRX Stock?
No significant insider selling has been recorded for MBRX in the recent period.
Is METABASIS THERAPEUTICS INC Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for MBRX is bullish with an Insider Alignment Score of 93/100 and a net flow of $9.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
MBRX Frequently Asked Questions
Understanding MBRX Insider Activity
Insider trading at METABASIS THERAPEUTICS INC (MBRX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading MBRX stock, having executed 137 transactions in the past 90 days. The most active insider is Suisse/ Credit (Executive), who has made 3 transactions totaling $4.2M.
Related Tools
Track METABASIS THERAPEUTICS INC Insider Activity
Get notified when executives and directors at MBRX file new Form 4 transactions